 | • レポートコード：GIR-2104Z14766 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ビノレルビンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ビノレルビンの種類別市場規模（経口、注射）、用途別市場規模（乳がん、非小細胞肺がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ビノレルビンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Pierre Fabre Pharmaceuticals, Inc.、TEVA Pharms、Hospira, Inc.、West-Ward Pharmaceuticals Corp.、Fresenius Kabi、EBEWE Pharma (Sandoz A Novartis Division)、Jiangsu Hansoh Pharmaceutical Group Co., Ltd.、Mylan、Dr. Reddy's Laboratories、Hangzhou Minsheng Pharmaceutical Group Co., Ltd.、Nanjing Cuccess Pharmaceutical Co., Ltd、Qilu Pharmaceutical (Hainan) Co., Ltd.、Sinopharm A-Think Pharmaceutical Co., Ltd.、Beijing SL Pharm、Shenzhen Main Luck Pharmaceuticals Inc.、Shanxi Powerdone Pharmaceutics Co., Ltd.、Luoxin Pharmaceutical Group Co., Ltd. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口、注射 ・用途別分析2016年-2026年：乳がん、非小細胞肺がん、その他 ・ビノレルビンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ビノレルビンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ビノレルビンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ビノレルビンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ビノレルビンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Vinorelbine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Vinorelbine size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Vinorelbine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Vinorelbine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Injection
Market segment by Application can be divided into
Breast Cancer
Non-small Cell Lung Cancer
Other
The key market players for global Vinorelbine market are listed below:
Pierre Fabre Pharmaceuticals, Inc.
TEVA Pharms
Hospira, Inc.
West-Ward Pharmaceuticals Corp.
Fresenius Kabi
EBEWE Pharma (Sandoz A Novartis Division)
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Mylan
Dr. Reddy’s Laboratories
Hangzhou Minsheng Pharmaceutical Group Co., Ltd.
Nanjing Cuccess Pharmaceutical Co., Ltd
Qilu Pharmaceutical (Hainan) Co., Ltd.
Sinopharm A-Think Pharmaceutical Co., Ltd.
Beijing SL Pharm
Shenzhen Main Luck Pharmaceuticals Inc.
Shanxi Powerdone Pharmaceutics Co., Ltd.
Luoxin Pharmaceutical Group Co., Ltd.
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Vinorelbine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Vinorelbine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Oral
1.2.3 Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Vinorelbine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Breast Cancer
1.3.3 Non-small Cell Lung Cancer
1.3.4 Other
1.4 Global Vinorelbine Market Size & Forecast
1.4.1 Global Vinorelbine Sales in Value (2016-2026))
1.4.2 Global Vinorelbine Sales in Volume (2016-2026)
1.4.3 Global Vinorelbine Price by Type (2016-2026) & (USD/Kg)
1.5 Global Vinorelbine Production Capacity Analysis
1.5.1 Global Vinorelbine Total Production Capacity (2016-2026)
1.5.2 Global Vinorelbine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Vinorelbine Market Drivers
1.6.2 Vinorelbine Market Restraints
1.6.3 Vinorelbine Trends Analysis
2 Manufacturers Profiles
2.1 Pierre Fabre Pharmaceuticals, Inc.
2.1.1 Pierre Fabre Pharmaceuticals, Inc. Details
2.1.2 Pierre Fabre Pharmaceuticals, Inc. Major Business
2.1.3 Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Product and Services
2.1.4 Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 TEVA Pharms
2.2.1 TEVA Pharms Details
2.2.2 TEVA Pharms Major Business
2.2.3 TEVA Pharms Vinorelbine Product and Services
2.2.4 TEVA Pharms Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Hospira, Inc.
2.3.1 Hospira, Inc. Details
2.3.2 Hospira, Inc. Major Business
2.3.3 Hospira, Inc. Vinorelbine Product and Services
2.3.4 Hospira, Inc. Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 West-Ward Pharmaceuticals Corp.
2.4.1 West-Ward Pharmaceuticals Corp. Details
2.4.2 West-Ward Pharmaceuticals Corp. Major Business
2.4.3 West-Ward Pharmaceuticals Corp. Vinorelbine Product and Services
2.4.4 West-Ward Pharmaceuticals Corp. Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Fresenius Kabi
2.5.1 Fresenius Kabi Details
2.5.2 Fresenius Kabi Major Business
2.5.3 Fresenius Kabi Vinorelbine Product and Services
2.5.4 Fresenius Kabi Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 EBEWE Pharma (Sandoz A Novartis Division)
2.6.1 EBEWE Pharma (Sandoz A Novartis Division) Details
2.6.2 EBEWE Pharma (Sandoz A Novartis Division) Major Business
2.6.3 EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Product and Services
2.6.4 EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
2.7.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Details
2.7.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Major Business
2.7.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Product and Services
2.7.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Vinorelbine Product and Services
2.8.4 Mylan Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Dr. Reddy’s Laboratories
2.9.1 Dr. Reddy’s Laboratories Details
2.9.2 Dr. Reddy’s Laboratories Major Business
2.9.3 Dr. Reddy’s Laboratories Vinorelbine Product and Services
2.9.4 Dr. Reddy’s Laboratories Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Hangzhou Minsheng Pharmaceutical Group Co., Ltd.
2.10.1 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Details
2.10.2 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Major Business
2.10.3 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Product and Services
2.10.4 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Nanjing Cuccess Pharmaceutical Co., Ltd
2.11.1 Nanjing Cuccess Pharmaceutical Co., Ltd Details
2.11.2 Nanjing Cuccess Pharmaceutical Co., Ltd Major Business
2.11.3 Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Product and Services
2.11.4 Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Qilu Pharmaceutical (Hainan) Co., Ltd.
2.12.1 Qilu Pharmaceutical (Hainan) Co., Ltd. Details
2.12.2 Qilu Pharmaceutical (Hainan) Co., Ltd. Major Business
2.12.3 Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Product and Services
2.12.4 Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Sinopharm A-Think Pharmaceutical Co., Ltd.
2.13.1 Sinopharm A-Think Pharmaceutical Co., Ltd. Details
2.13.2 Sinopharm A-Think Pharmaceutical Co., Ltd. Major Business
2.13.3 Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Product and Services
2.13.4 Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Beijing SL Pharm
2.14.1 Beijing SL Pharm Details
2.14.2 Beijing SL Pharm Major Business
2.14.3 Beijing SL Pharm Vinorelbine Product and Services
2.14.4 Beijing SL Pharm Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Shenzhen Main Luck Pharmaceuticals Inc.
2.15.1 Shenzhen Main Luck Pharmaceuticals Inc. Details
2.15.2 Shenzhen Main Luck Pharmaceuticals Inc. Major Business
2.15.3 Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Product and Services
2.15.4 Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Shanxi Powerdone Pharmaceutics Co., Ltd.
2.16.1 Shanxi Powerdone Pharmaceutics Co., Ltd. Details
2.16.2 Shanxi Powerdone Pharmaceutics Co., Ltd. Major Business
2.16.3 Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Product and Services
2.16.4 Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.17 Luoxin Pharmaceutical Group Co., Ltd.
2.17.1 Luoxin Pharmaceutical Group Co., Ltd. Details
2.17.2 Luoxin Pharmaceutical Group Co., Ltd. Major Business
2.17.3 Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Product and Services
2.17.4 Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Vinorelbine Sales by Manufacturer
3.1 Global Vinorelbine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Vinorelbine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Vinorelbine
3.4 Market Concentration Rate
3.4.1 Top 3 Vinorelbine Manufacturer Market Share
3.4.2 Top 6 Vinorelbine Manufacturer Market Share
3.5 Global Vinorelbine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Vinorelbine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Vinorelbine Market Size by Region
4.1.1 Global Vinorelbine Sales in Volume by Region (2016-2026)
4.1.2 Global Vinorelbine Revenue by Region (2016-2026)
4.2 North America Vinorelbine Revenue (2016-2026)
4.3 Europe Vinorelbine Revenue (2016-2026)
4.4 Asia-Pacific Vinorelbine Revenue (2016-2026)
4.5 South America Vinorelbine Revenue (2016-2026)
4.6 Middle East and Africa Vinorelbine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Vinorelbine Sales in Volume by Type (2016-2026)
5.2 Global Vinorelbine Revenue by Type (2016-2026)
5.3 Global Vinorelbine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Vinorelbine Sales in Volume by Application (2016-2026)
6.2 Global Vinorelbine Revenue by Application (2016-2026)
6.3 Global Vinorelbine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Vinorelbine Sales by Type (2016-2026)
7.2 North America Vinorelbine Sales by Application (2016-2026)
7.3 North America Vinorelbine Market Size by Country
7.3.1 North America Vinorelbine Sales in Volume by Country (2016-2026)
7.3.2 North America Vinorelbine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Vinorelbine Sales by Type (2016-2026)
8.2 Europe Vinorelbine Sales by Application (2016-2026)
8.3 Europe Vinorelbine Market Size by Country
8.3.1 Europe Vinorelbine Sales in Volume by Country (2016-2026)
8.3.2 Europe Vinorelbine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Vinorelbine Sales by Type (2016-2026)
9.2 Asia-Pacific Vinorelbine Sales by Application (2016-2026)
9.3 Asia-Pacific Vinorelbine Market Size by Region
9.3.1 Asia-Pacific Vinorelbine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Vinorelbine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Vinorelbine Sales by Type (2016-2026)
10.2 South America Vinorelbine Sales by Application (2016-2026)
10.3 South America Vinorelbine Market Size by Country
10.3.1 South America Vinorelbine Sales in Volume by Country (2016-2026)
10.3.2 South America Vinorelbine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Vinorelbine Sales by Type (2016-2026)
11.2 Middle East & Africa Vinorelbine Sales by Application (2016-2026)
11.3 Middle East & Africa Vinorelbine Market Size by Country
11.3.1 Middle East & Africa Vinorelbine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Vinorelbine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Vinorelbine Typical Distributors
12.3 Vinorelbine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Vinorelbine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Vinorelbine Revenue by Application, (USD Million), 2021-2026
Table 3. Pierre Fabre Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Pierre Fabre Pharmaceuticals, Inc. Major Business
Table 5. Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Product and Services
Table 6. Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. TEVA Pharms Basic Information, Manufacturing Base and Competitors
Table 8. TEVA Pharms Major Business
Table 9. TEVA Pharms Vinorelbine Product and Services
Table 10. TEVA Pharms Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Hospira, Inc. Basic Information, Manufacturing Base and Competitors
Table 12. Hospira, Inc. Major Business
Table 13. Hospira, Inc. Vinorelbine Product and Services
Table 14. Hospira, Inc. Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. West-Ward Pharmaceuticals Corp. Basic Information, Manufacturing Base and Competitors
Table 16. West-Ward Pharmaceuticals Corp. Major Business
Table 17. West-Ward Pharmaceuticals Corp. Vinorelbine Product and Services
Table 18. West-Ward Pharmaceuticals Corp. Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 20. Fresenius Kabi Major Business
Table 21. Fresenius Kabi Vinorelbine Product and Services
Table 22. Fresenius Kabi Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. EBEWE Pharma (Sandoz A Novartis Division) Basic Information, Manufacturing Base and Competitors
Table 24. EBEWE Pharma (Sandoz A Novartis Division) Major Business
Table 25. EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Product and Services
Table 26. EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 28. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Major Business
Table 29. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Product and Services
Table 30. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Mylan Basic Information, Manufacturing Base and Competitors
Table 32. Mylan Major Business
Table 33. Mylan Vinorelbine Product and Services
Table 34. Mylan Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 36. Dr. Reddy's Laboratories Major Business
Table 37. Dr. Reddy's Laboratories Vinorelbine Product and Services
Table 38. Dr. Reddy's Laboratories Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 40. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Major Business
Table 41. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Product and Services
Table 42. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Nanjing Cuccess Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Nanjing Cuccess Pharmaceutical Co., Ltd Major Business
Table 45. Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Product and Services
Table 46. Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Qilu Pharmaceutical (Hainan) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 48. Qilu Pharmaceutical (Hainan) Co., Ltd. Major Business
Table 49. Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Product and Services
Table 50. Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Sinopharm A-Think Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 52. Sinopharm A-Think Pharmaceutical Co., Ltd. Major Business
Table 53. Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Product and Services
Table 54. Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Beijing SL Pharm Basic Information, Manufacturing Base and Competitors
Table 56. Beijing SL Pharm Major Business
Table 57. Beijing SL Pharm Vinorelbine Product and Services
Table 58. Beijing SL Pharm Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Shenzhen Main Luck Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 60. Shenzhen Main Luck Pharmaceuticals Inc. Major Business
Table 61. Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Product and Services
Table 62. Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Shanxi Powerdone Pharmaceutics Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 64. Shanxi Powerdone Pharmaceutics Co., Ltd. Major Business
Table 65. Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Product and Services
Table 66. Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Luoxin Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 68. Luoxin Pharmaceutical Group Co., Ltd. Major Business
Table 69. Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Product and Services
Table 70. Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Global Vinorelbine Sales by Manufacturer (2019-2021e) & (MT)
Table 72. Global Vinorelbine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 73. Market Position of Manufacturers in Vinorelbine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 74. Global Vinorelbine Production Capacity by Company, (MT): 2020 VS 2021
Table 75. Head Office and Vinorelbine Production Site of Key Manufacturer
Table 76. Global Vinorelbine Sales by Region (2016-2021e) & (MT)
Table 77. Global Vinorelbine Sales by Region (2021-2026) & (MT)
Table 78. Global Vinorelbine Revenue by Region (2016-2021e) & (USD Million)
Table 79. Global Vinorelbine Revenue by Region (2021-2026) & (USD Million)
Table 80. Global Vinorelbine Sales by Type (2016-2021e) & (MT)
Table 81. Global Vinorelbine Sales by Type (2021-2026) & (MT)
Table 82. Global Vinorelbine Revenue by Type (2016-2021e) & (USD Million)
Table 83. Global Vinorelbine Revenue by Type (2021-2026) & (USD Million)
Table 84. Global Vinorelbine Price by Type (2016-2021e) & (USD/Kg)
Table 85. Global Vinorelbine Price by Type (2021-2026) & (USD/Kg)
Table 86. Global Vinorelbine Sales by Application (2016-2021e) & (MT)
Table 87. Global Vinorelbine Sales by Application (2021-2026) & (MT)
Table 88. Global Vinorelbine Revenue by Application (2016-2021e) & (USD Million)
Table 89. Global Vinorelbine Revenue by Application (2021-2026) & (USD Million)
Table 90. Global Vinorelbine Price by Application (2016-2021e) & (USD/Kg)
Table 91. Global Vinorelbine Price by Application (2021-2026) & (USD/Kg)
Table 92. North America Vinorelbine Sales by Country (2016-2021e) & (MT)
Table 93. North America Vinorelbine Sales by Country (2021-2026) & (MT)
Table 94. North America Vinorelbine Revenue by Country (2016-2021e) & (USD Million)
Table 95. North America Vinorelbine Revenue by Country (2021-2026) & (USD Million)
Table 96. North America Vinorelbine Sales by Type (2016-2021e) & (MT)
Table 97. North America Vinorelbine Sales by Type (2021-2026) & (MT)
Table 98. North America Vinorelbine Sales by Application (2016-2021e) & (MT)
Table 99. North America Vinorelbine Sales by Application (2021-2026) & (MT)
Table 100. Europe Vinorelbine Sales by Country (2016-2021e) & (MT)
Table 101. Europe Vinorelbine Sales by Country (2021-2026) & (MT)
Table 102. Europe Vinorelbine Revenue by Country (2016-2021e) & (USD Million)
Table 103. Europe Vinorelbine Revenue by Country (2021-2026) & (USD Million)
Table 104. Europe Vinorelbine Sales by Type (2016-2021e) & (MT)
Table 105. Europe Vinorelbine Sales by Type (2021-2026) & (MT)
Table 106. Europe Vinorelbine Sales by Application (2016-2021e) & (MT)
Table 107. Europe Vinorelbine Sales by Application (2021-2026) & (MT)
Table 108. Asia-Pacific Vinorelbine Sales by Region (2016-2021e) & (MT)
Table 109. Asia-Pacific Vinorelbine Sales by Region (2021-2026) & (MT)
Table 110. Asia-Pacific Vinorelbine Revenue by Region (2016-2021e) & (USD Million)
Table 111. Asia-Pacific Vinorelbine Revenue by Region (2021-2026) & (USD Million)
Table 112. Asia-Pacific Vinorelbine Sales by Type (2016-2021e) & (MT)
Table 113. Asia-Pacific Vinorelbine Sales by Type (2021-2026) & (MT)
Table 114. Asia-Pacific Vinorelbine Sales by Application (2016-2021e) & (MT)
Table 115. Asia-Pacific Vinorelbine Sales by Application (2021-2026) & (MT)
Table 116. South America Vinorelbine Sales by Country (2016-2021e) & (MT)
Table 117. South America Vinorelbine Sales by Country (2021-2026) & (MT)
Table 118. South America Vinorelbine Revenue by Country (2016-2021e) & (USD Million)
Table 119. South America Vinorelbine Revenue by Country (2021-2026) & (USD Million)
Table 120. South America Vinorelbine Sales by Type (2016-2021e) & (MT)
Table 121. South America Vinorelbine Sales by Type (2021-2026) & (MT)
Table 122. South America Vinorelbine Sales by Application (2016-2021e) & (MT)
Table 123. South America Vinorelbine Sales by Application (2021-2026) & (MT)
Table 124. Middle East & Africa Vinorelbine Sales by Country (2016-2021e) & (MT)
Table 125. Middle East & Africa Vinorelbine Sales by Country (2021-2026) & (MT)
Table 126. Middle East & Africa Vinorelbine Revenue by Country (2016-2021e) & (USD Million)
Table 127. Middle East & Africa Vinorelbine Revenue by Country (2021-2026) & (USD Million)
Table 128. Middle East & Africa Vinorelbine Sales by Type (2016-2021e) & (MT)
Table 129. Middle East & Africa Vinorelbine Sales by Type (2021-2026) & (MT)
Table 130. Middle East & Africa Vinorelbine Sales by Application (2016-2021e) & (MT)
Table 131. Middle East & Africa Vinorelbine Sales by Application (2021-2026) & (MT)
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Vinorelbine Typical Distributors
Table 135. Vinorelbine Typical Customers
List of Figures
Figure 1. Vinorelbine Picture
Figure 2. Global Vinorelbine Sales Market Share by Type in 2020
Figure 3. Oral
Figure 4. Injection
Figure 5. Global Vinorelbine Sales Market Share by Application in 2020
Figure 6. Breast Cancer
Figure 7. Non-small Cell Lung Cancer
Figure 8. Other
Figure 9. Global Vinorelbine Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 10. Global Vinorelbine Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Vinorelbine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Vinorelbine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Vinorelbine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Vinorelbine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Vinorelbine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Vinorelbine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Vinorelbine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Vinorelbine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Vinorelbine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Vinorelbine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Vinorelbine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Vinorelbine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Vinorelbine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Vinorelbine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Vinorelbine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Vinorelbine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Vinorelbine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Vinorelbine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Vinorelbine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Vinorelbine Sales (2016-2026) & (MT)
Figure 31. Global Vinorelbine Production Capacity (2016-2026) & (MT)
Figure 32. Global Vinorelbine Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Vinorelbine Market Drivers
Figure 34. Vinorelbine Market Restraints
Figure 35. Vinorelbine Market Trends
Figure 36. Global Vinorelbine Sales Market Share by Manufacturer in 2020
Figure 37. Global Vinorelbine Revenue Market Share by Manufacturer in 2020
Figure 38. Vinorelbine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Vinorelbine Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Vinorelbine Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Vinorelbine Sales Market Share by Region (2016-2026)
Figure 42. Global Vinorelbine Revenue Market Share by Region (2016-2026)
Figure 43. North America Vinorelbine Revenue (2016-2026) & (USD Million)
Figure 44. Europe Vinorelbine Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Vinorelbine Revenue (2016-2026) & (USD Million)
Figure 46. South America Vinorelbine Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Vinorelbine Revenue (2016-2026) & (USD Million)
Figure 48. Global Vinorelbine Sales Market Share by Type (2016-2026)
Figure 49. Global Vinorelbine Revenue Market Share by Type (2016-2026)
Figure 50. Global Vinorelbine Price by Type (2016-2026) & (USD/Kg)
Figure 51. Global Vinorelbine Sales Market Share by Application (2016-2026)
Figure 52. Global Vinorelbine Revenue Market Share by Application (2016-2026)
Figure 53. Global Vinorelbine Price by Application (2016-2026) & (USD/Kg)
Figure 54. North America Vinorelbine Sales Market Share by Country (2016-2026)
Figure 55. North America Vinorelbine Revenue Market Share by Country (2016-2026)
Figure 56. North America Vinorelbine Sales Market Share by Type (2016-2026)
Figure 57. North America Vinorelbine Sales Market Share by Application (2016-2026)
Figure 58. Europe Vinorelbine Sales Market Share by Country (2016-2026)
Figure 59. Europe Vinorelbine Revenue Market Share by Country (2016-2026)
Figure 60. Europe Vinorelbine Sales Market Share by Type (2016-2026)
Figure 61. Europe Vinorelbine Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Vinorelbine Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Vinorelbine Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Vinorelbine Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Vinorelbine Sales Market Share by Application (2016-2026)
Figure 66. South America Vinorelbine Sales Market Share by Country (2016-2026)
Figure 67. South America Vinorelbine Revenue Market Share by Country (2016-2026)
Figure 68. South America Vinorelbine Sales Market Share by Type (2016-2026)
Figure 69. South America Vinorelbine Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Vinorelbine Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Vinorelbine Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Vinorelbine Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Vinorelbine Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界の小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data…- 世界の小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data…
- 世界の非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Non-small Cell Lung Cancer Therapeutics Market The global Non-small Cell Lung Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…
- 世界の小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell car…
- 世界の小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell car…